THE IMMUNE-RESPONSE TO DIFFERENT DOSES OF INACTIVATED HEPATITIS-A VACCINE

被引:5
|
作者
JILG, W [1 ]
BITTNER, R [1 ]
SCHATZL, H [1 ]
RASSHOFER, R [1 ]
SCHMIDT, M [1 ]
DEINHARDT, F [1 ]
机构
[1] UNIV MUNICH, MAX VON PETTENKOFER INST HYG & MED MICROBIOL, MUNICH, GERMANY
关键词
HEPATITIS A VACCINE; IMMUNOGENICITY; TOLERABILITY; DOSAGE; KINETICS OF IMMUNE RESPONSE;
D O I
10.1016/S0168-8278(05)80376-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The immunogenicity and reactogenicity of different doses of hepatitis A vaccine was studied in healthy adult volunteers. Vaccinees (105) were immunized with 6.25, 12.5 or 25 ng of HAV antigen, each dose administered at 0, 1 and 6 months (groups B, C and D); one group (group A) obtained three 6.25 ng doses at 0, 1 and 2 months. After one single dose high seroconversion rates ranging between 63 and 85% were observed in all four groups. All participants had seroconverted after the third dose, irrespective of the antigen content per dose and the vaccination schedule. Geometric mean titers after three doses were 439 IU/l (group A, month 3) and 1492, 963 and 2772 IU/l in groups B, C and D at month 7. One year after the first injection all vaccinees tested still showed antibody levels well above 10 IU/l. The vaccine was very well tolerated. Minor localized symptoms were observed mainly such as slight pain at the injection site. These symptoms were not dose related; no serious side effects occurred.
引用
收藏
页码:S38 / S40
页数:3
相关论文
共 50 条
  • [1] PREPARATION AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VACCINE
    PELLEGRINI, V
    FINESCHI, N
    MATTEUCCI, G
    MARSILI, I
    NENCIONI, L
    PUDDU, M
    GARELICK, H
    ZUCKERMAN, AJ
    VACCINE, 1993, 11 (03) : 383 - 387
  • [2] A TRIAL OF THE REACTOGENICITY AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VACCINE
    GREEN, MS
    COHEN, D
    LERMAN, Y
    SJOGREN, M
    BINN, LN
    ZUR, S
    SLEPON, R
    ROBIN, G
    HOKE, C
    BANCROFT, W
    SAFARY, A
    DANON, Y
    WIENER, M
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1994, 30 (5-6): : 485 - 488
  • [3] Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine
    Nirmal, S
    Cherian, T
    Samuel, BU
    Rajasingh, J
    Raghupathy, P
    John, TJ
    VACCINE, 1998, 16 (9-10) : 928 - 931
  • [4] IMMUNOGENICITY, SAFETY, AND CONSISTENCY OF AN INACTIVATED HEPATITIS-A VACCINE - A RANDOMIZED CONTROLLED MULTICENTER STUDY WITH 3 DIFFERENT VACCINE LOTS
    KALLINOWSKI, B
    THEILMANN, L
    GMELIN, K
    KOMMERELL, B
    HOFMANN, F
    SCHEIERMANN, N
    WOHLAND, B
    STICKL, H
    MAIWALD, H
    MORIABADI, FK
    BOCK, HL
    CLEMENS, R
    INNERE MEDIZIN, 1992, 19 (02) : 41 - 44
  • [5] INADEQUATE RESPONSE TO INTRADERMAL HEPATITIS-A VACCINE
    BRINDLE, RJ
    MORRIS, CA
    BERGER, R
    KURTZ, JB
    VACCINE, 1994, 12 (06) : 483 - 484
  • [6] IMMUNE-RESPONSE AFTER HEPATITIS-A VACCINATION IN HEMODIALYSIS-PATIENTS - COMPARISON WITH HEPATITIS-B VACCINATION
    KURAMOTO, I
    FUJIYAMA, S
    MATSUSHITA, K
    SATO, T
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1994, 9 (03) : 228 - 231
  • [7] CLINICAL-ASSESSMENT OF THE SAFETY AND EFFICACY OF AN INACTIVATED HEPATITIS-A VACCINE - RATIONALE AND SUMMARY OF FINDINGS
    ANDRE, FE
    DHONDT, E
    DELEM, A
    SAFARY, A
    VACCINE, 1992, 10 : S160 - S168
  • [8] IMMUNOGENICITY AND SAFETY OF A NEW INACTIVATED HEPATITIS-A VACCINE IN A COMPARATIVE-STUDY
    GOILAV, C
    ZUCKERMAN, J
    LAFRENZ, M
    VIDOR, E
    LAUWERS, S
    RATHEAU, C
    BENICHOU, G
    ZUCKERMAN, A
    JOURNAL OF MEDICAL VIROLOGY, 1995, 46 (03) : 287 - 292
  • [9] SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VACCINE - EFFECTS OF SINGLE AND BOOSTER INJECTIONS, AND COMPARISON TO ADMINISTRATION OF IMMUNE GLOBULIN
    SHOUVAL, D
    ASHUR, Y
    ADLER, R
    LEWIS, JA
    MILLER, W
    KUTER, B
    BROWN, L
    NALIN, DR
    JOURNAL OF HEPATOLOGY, 1993, 18 : S32 - S37
  • [10] SAFETY PROFILE AND IMMUNOGENICITY OF AN INACTIVATED VACCINE DERIVED FROM AN ATTENUATED STRAIN OF HEPATITIS-A
    ELLERBECK, EF
    LEWIS, JA
    NALIN, D
    GERSHMAN, K
    MILLER, WJ
    ARMSTRONG, ME
    DAVIDE, JP
    RHOAD, AE
    MCGUIRE, B
    CALANDRA, G
    PROVOST, PJ
    MIDTHUN, K
    VACCINE, 1992, 10 (10) : 668 - 672